Protocol for the 3HP Options Trial: a hybrid type 3 implementation-effectiveness randomized trial of delivery strategies for short-course tuberculosis preventive therapy among people living with HIV in Uganda

BACKGROUND: Recently, a 3-month (12-dose) regimen of weekly isoniazid and rifapentine (3HP) was recommended by the World Health Organization for the prevention of tuberculosis (TB) among people living with HIV (PLHIV) on common antiretroviral therapy regimens. The best approach to delivering 3HP to...

Descripción completa

Detalles Bibliográficos
Autores principales: Kadota, Jillian L., Musinguzi, Allan, Nabunje, Juliet, Welishe, Fred, Ssemata, Jackie L., Bishop, Opira, Berger, Christopher A., Patel, Devika, Sammann, Amanda, Katahoire, Anne, Nahid, Payam, Belknap, Robert, Phillips, Patrick P. J., Namusobya, Jennifer, Kamya, Moses, Handley, Margaret A., Kiwanuka, Noah, Katamba, Achilles, Dowdy, David, Semitala, Fred C., Cattamanchi, Adithya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7425004/
https://www.ncbi.nlm.nih.gov/pubmed/32787925
http://dx.doi.org/10.1186/s13012-020-01025-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7425004/
https://www.ncbi.nlm.nih.gov/pubmed/32787925
http://dx.doi.org/10.1186/s13012-020-01025-8

Ejemplares similares